NREP
NEW REPRESENTATIVE AT IB RECEIVED
30/11/2025
Voltar para busca
Dado oficial do USPTO
MACUNEOS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
39
Atualização mais recente
01/12/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
3, 5, 42
Data de depósito
03/08/2016
Data de registro
06/03/2018
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
20/09/2024
Última transação
01/12/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
709
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
FR
Examinador
ANDERSON, CASSONDRA CR
Unidade examinadora
L30
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
BIOPHYTIS, société anonyme
Representantes
Cynthia A. Moyer Fredrikson & Byron, P.A.
Classificação técnica
Classes Nice
Classe 3Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 3
Soapsnamely perfumed soapsbeauty soapsshaving soapsbath soapscosmetic soaps; perfumesessential oilscosmeticshair lotions; cosmetic preparations for slimming purposes for external use
Classe 5
Pharmaceutical products for the prevention and treatment of aging diseasesAlzheimer'sParkinson'sHuntington'smultiple sclerosissarcopeniacardiovascular diseasesdiabetesspinal cord disordersage-related macular degeneration (ARMD)diabetic retinopathy and other retinopathy as pigmentary retinitis or Stargaardt diseasesocular diseases; dietetic substances and foods for medical use; food supplements for human beings; sanitary products for medical purposesmedicinal astringentsdisinfectants for medical instrumentsbody care soapsdisinfectant soapspersonal soapsantifungal creams for medical uselotions for the body and shampoos without rinsingrubbing alcohol for medical useskin cleansers for medical use; medical plasters; materials for medical dressingsbandagesdressings and medical gauzesabsorbent cotton for bandagesbands and strips for bandages; material for stopping teeth and for dental impressions; disinfectants; vermin destroying preparations; fungicides; herbicides; medicated baths preparations; sanitary padspanties or towels; chemical preparations for medical usechemical preparations for reactive preparations for clinical laboratorydiagnostic preparations for medical laboratory; chemical preparations for pharmaceutical usepreventive pharmaceutical agents for cerebral hemorrhagerelease agents of medicines in the form of edible wafers for the conditioning of pharmaceutical products in the form of powderpharmaceutical astringentsesters of celluloses for the manufacturing of pharmaceutical products; parasiticides; dietetic sugar for medical use; alloys of precious metals for dental use; dietetic substances for medical use produced by organic farming or made with goods produced by organic farmingfood for babies
Classe 42
Evaluationsassessments and research in the field of science and technology provided by engineers; research and development of new products for others; technical project studies in scientific and technologic fieldsfeasibility study; technological studies in the field of pharmaceutical research and development; technical research in the field of pharmaceutical research and development; research in the field of pharmaceutical products; biologicalclinical and medical research services; biotechnological research; scientific research for medical purposes in the field of pharmaceutical products to treat dry age-related macular degeneration and diseases of ageing; computer-aided scientific research services in the field of pharmaceutical products to treat dry age-related macular degeneration and diseases of ageing; providing information relating to scientific research; preparation of reports relating to scientific research; advice relating to research and development in the therapeutic field; providing information and data relating to medical and veterinary research and development; design and development of computers and software; installationmaintenance and updating or rental of software; programming for computers; consultancy relating to computers; conversion of computer programs and data other than physical conversion; conversion of documents from a physical medium to an electronic medium
Publicações
Histórico de despachos e eventos da marca no USPTO.
39 publicações encontradas
INNT
TOTAL INVALIDATION PROCESSED BY THE IB
18/10/2025
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
25/09/2025
INPC
INVALIDATION PROCESSED
24/09/2025
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
20/05/2025
C71T
CANCELLED SECTION 71
20/09/2024
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
06/03/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
13/07/2018
FICS
FINAL DISPOSITION NOTICE SENT TO IB
08/06/2018
FIMP
FINAL DISPOSITION PROCESSED
08/06/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/06/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
06/03/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
19/12/2017
PUBO
PUBLISHED FOR OPPOSITION
19/12/2017
GPNX
NOTIFICATION PROCESSED BY IB
15/12/2017
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
29/11/2017
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
29/11/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
29/11/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
14/11/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
14/11/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
14/11/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
14/11/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
14/11/2017
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
08/11/2017
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
24/10/2017
ALIE
ASSIGNED TO LIE
09/10/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
22/09/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
21/09/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
20/09/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
20/09/2017
RFNT
REFUSAL PROCESSED BY IB
03/06/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
16/05/2017
RFRR
REFUSAL PROCESSED BY MPU
16/05/2017
MAFR
APPLICATION FILING RECEIPT MAILED
13/05/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/05/2017
CNRT
NON-FINAL ACTION WRITTEN
09/05/2017
DOCK
ASSIGNED TO EXAMINER
09/05/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/05/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/05/2017
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace MACUNEOS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.